Soleus Capital Management, L.P. Magenta Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $546,300 - $890,100	-90,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.76 - $14.15 $97,600 - $141,500	-10,000 Reduced 10.0%	90,000 $880,000
Q1 2021 May 17, 2021	BUY	$7.66 - $13.38 $766,000 - $1.34 Million	100,000 New	100,000 $1.18 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.